L-leucyl-L-leucine methyl ester (LLME)

DRUG2 trials

Sponsors

Sidney Kimmel Cancer Center at Thomas Jefferson University

Conditions

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONHematologic Malignancies

Phase 1

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

CompletedNCT00429416

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityHematologic Malignancies

Start: 2004-03-31End: 2009-05-31Updated: 2016-11-29

Phase 2

A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation

TerminatedNCT00429039

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Start: 2000-09-30End: 2009-08-31Updated: 2016-10-21